In vivo modulation of G proteins and opioid receptor function by antisense oligodeoxynucleotides

Methods in Enzymology

Volumn 314, Issue , 2000, Pages 3-20

  Garzón, Javier ^a   De Antonio, Isabel ^a   Sánchez Blázquez, Pilar ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MORPHINE; NEUROTRANSMITTER RECEPTOR; OPIATE AGONIST; OPIATE RECEPTOR;

ANALGESIA; ANIMAL TISSUE; ANTINOCICEPTION; AUTORADIOGRAPHY; CELL MEMBRANE; CONTROLLED STUDY; ELECTROPHORESIS; FLUORESCENCE ANALYSIS; IMMUNOBLOTTING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; NUCLEIC ACID PROBE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032758137     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(99)14091-6     Document Type: Article

References (48)

1. Y. Chen, A. Mestek, J. Liu, J. A. Hurley, and L. Yu, Mol. Pharmacol. 44, 8 (1993).
2. R. C. Thompson, A. Mansour, H. Akil, and S. J. Watson, Neuron 11, 903 (1993).
3. C. J. Evans, D. E. Keith, H. Morrison, K. Magendzo, and R. H. Edwards, Science 28, 1952 (1992).
4. B. L. Kieffer, K. Befort, C. Gaveriaux-Ruff, and C. G. Hirth, Proc. Natl. Acad. Sci. U.S.A. 89, 12048 (1992).
5. G. X. Xie, F. Meng, A. Mansour, R. C. Thompson, M. T. Hoversten, A. Goldstein, S. T. Watson, and H. Akil, Proc. Acad. Natl. Sci. U.S.A. 91, 3779 (1994).
6. H. E. Hamm and A. Gilchrist, Curr. Opin. Cell Biol. 8, 189 (1996).
7. E. J. Neer and T. F. Smith, Cell 84, 175 (1996).
8. D. G. Lambright, J. Sondek, A. Bohm, N. P. Skiba, H. E. Hamm, and P. B. Sigler, Nature (London) 379, 311 (1996).
9. D. T. Jones and R. R. Reed, J. Biol. Chem. 262, 14241 (1987).
10. H. Ueda, Y. Yoshihara, H. Misawa, N. Fukushima, M. Ui, H. Takagi, and M. Satoh, J. Biol. Chem. 264, 3732 (1989).
11. S. F. Law, S. Zaina, R. Sweet, K. Yasuda, G. I. Bell, J. Stadel, and T. Reisine, Mol. Pharmacol. 45, 587 (1994).
12. Y. F. Lui, K. H. Jacobs, M. M. Rasenick, and P. R. Albert, J. Biol. Chem. 269, 13880 (1994).
13. S. Offermanns, T. Wieland, D. Homann, J. Sandmann, E. Bombien, K. Spicher, G. Schultz, and K. H. Jakobs, Mol. Pharmacol. 45, 890 (1994).
14. C. W. Taylor, Biochem. J. 272, 1 (1990).
15. A. D. Strosberg, Eur. J. Biochem. 196, 1 (1991).
16. J. Garzón, M. A. Castro, J. L. Juarros, and P. Sánchez-Blázquez, Life Sci.-Pharmacol. Lett. 54, PL191 (1994).
17. J. Garzón, A. García-España, and P. Sánchez-Blázquez, J. Pharmacol. Exp. Ther. 281, 549 (1997).
18. J. Garzón, M. Castro, and P. Sánchez-Blázquez, Eur. J. Neurosci. 10, 2557 (1998).
19. M. D. Matteucci and M. H. Carouthers, J. Am. Chem. Soc. 103, 3185 (1981).
20. H. Vu and B. L. Hirschbein, Tetrahedron Lett. 32, 3005 (1991).
21. P. Sánchez-Blázquez, A. García-España, and J. Garzón, J. Pharmacol. Exp. Ther. 275, 1590 (1995).
22. E. J. Bilsky, R. N. Bernstein, V. J. Hruby, R. B. Rothman, J. Lai, and F. Porreca, J. Pharmacol. Exp. Ther. 277, 491 (1996).
23. B. J. Chiasson, J. N. Armstrong, M. L. Hooper, P. R. Murphy, and H. A. Robertson, Cell. Mol. Neurobiol. 14, 507 (1994).
24. C. C. H. Yang, J. Y. H. Chang, and S. H. H. Chan, Endocrinology 132, 495 (1993).
25. J. Garzón and P. Sánchez-Blázquez, Life Sci.-Pharmacol Lett. 56, PL237 (1995).
26. J. Garzón, J. L. Juarros, M. A. Castro, and P. Sánchez-Blázquez, Mol. Pharmacol. 47, 738 (1995).
27. F. C. Greenwood, W. M. Hunter, and J. S. Glover, Biochem. J. 308, 299 (1985).
28. P. Sánchez-Blázquez, A. García-España, and J. Garzón, J. Pharmacol. Exp. Ther. 280, 1423 (1997).
29. L.-Y. Liu-Chen, C. Chen, and C. A. Phillips, Mol. Pharmacol. 44, 749 (1993).
30. P. Sánchez-Blázquez and J. Garzón, J. Pharmacol. Exp. Ther. 285, 820 (1998).
31. B. H. Shah and G. Milligan, Mol. Pharmacol. 46, 1 (1994).
32. I. Mullaney and G. Milligan, J. Neurochem. 55, 1890 (1990).
33. K. M. Standifer, G. C. Rossi, and G. W. Pasternak, Mol. Pharmacol. 50, 293 (1996).
34. J. Shen, S. Shah, H. Hsu, and B. C. Yoburn, Mol. Brain Res. 59, 247 (1988).
35. C. Wahlestedt, E. M. Pich, G. F. Koob, F. Yee, and M. Helling, Science 259, 528 (1993).
36. M. Zhang and I. Creese, Neurosci. Lett. 161, 223 (1993).
37. G. Rossi, L. Leventhal, Y.-X. Pan, J. Cole, W. Su, R. J. Bodnar, and G. W. Pasternak, J. Pharmacol. Exp. Ther. 281, 109 (1997).
38. X.-H. Chen, J. U. Adams, E. B. Geller, J. K. Deriel, M. W. Adler, and L.-Y. Liu-Chen, Eur. J. Pharmacol. 275, 105 (1995).
39. P. Sánchez-Blázquez, I. DeAntonio, M. Rodríguez-Díaz, and J. Garzón, Antisense Nucl. Acid Drug Dev. 9, 253 (1999).
40. K. M. Standifer, C.-C. Chien, C. Wahlestedt, G. P. Brown, and G. W. Pasternak, Neuron 12, 805 (1994).
41. L. F. Tseng, K. A. Collins, and J. P. Kampine, Eur. J. Pharmacol. 258, R1 (1994).
42. G. C. Rossi, W. Su, H. Leventhal, and G. W. Pasternak, Brain Res. 753, 176 (1997).
43. C. C. Chien, G. Brown, Y. X. Pan, and G. W. Pasternak, Eur. J. Pharmacol. 253, R7 (1994).
44. J. Lai, E. J. Bilsky, R. B. Rothman, and F. Porreca, Neuroreport 5, 1049 (1994).
45. R. B. Raffa, R. P. Martinez, and C. D. Connelly, Eur. J. Pharmacol. 258, R5 (1994).
46. G. C. Rossi, K. M. Sandifer, and G. W. Pasternak, Neurosci. Lett. 198, 99 (1995).
47. J. Garzón, M. Castro, and P. Sánchez-Blázquez, Analgesia 1, 4 (1995).
48. J. Garzón, Y. Martínez-Pena, and P. Sánchez-Blázquez, Eur. J. Neurosci. 9, 1194 (1997).